facebook-page-view
Advertisement

Why PEs, VCs are holding back from investing in the stem cell market

By Joseph Rai

  • 21 Jul 2017
Premium
Why PEs, VCs are holding back from investing in the stem cell market
Credit: Reuters

In 2009, when eight-year-old Thamirabarani was cured of thalassaemia, a rare blood disorder, LifeCell International Pvt. Ltd made ripples in the fledgling Indian stem cell market.The Chennai-based company, which was founded in 2004, had stored her new-born brother’s umbilical cord blood, which was used for her treatment. It was a ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement